Beyond Body Weight: Biological and Clinical Determinants of Factor VIII Pharmacokinetics in Tunisian Patients
Haemophilia · 2026-11 · 32 (6) · 1413-1420
DOI: 10.1111/hae.70335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, online erschienen am 15.06.2026. Verfasst von Sameh Neji und 5 weiteren Autor:innen. Beteiligte Einrichtung: Haemophilia Treatment Centre, Aziza Othmana Hospital, Tunis, Tunisia. Hauptthemen laut MEDLINE: Factor VIII, Hemophilia A, Body Weight. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Introduction
Inter‐individual variability in factor VIII (FVIII) pharmacokinetics (PK) is well recognized in people with haemophilia A (PWH‐A) and may compromise the effectiveness of prophylaxis. This variability is partially explained by clinical and biological determinants, including age, anthropometric parameters and von Willebrand factor antigen (VWF:Ag) levels.
Aim
To identify the determinants of FVIII‐PK in Tunisian PWH‐A and assess their implications for PK‐guided prophylaxis.
Methods
A prospective PK study was conducted in 25 people with severe or moderate haemophilia A enrolled between December 2022 and December 2024. Following a 72‐hour wash‐out, PWH‐A received standard half‐life FVIII concentrates. FVIII activity was measured using one‐stage assay (OSA) and chromogenic substrate assay (CSA) at baseline, 30 min, 5 h ±1 h, 24 h and 48 h post‐infusion. PK parameters—half‐life, clearance, in vivo recovery and area under curve (AUC)‐ were calculated and correlated with age, anthropometric parameters, ABO blood group and VWF:Ag levels.
Results
FVIII activity measured by OSA and CSA showed a strong correlation ( p < 0.0001). Higher VWF:Ag levels were associated with longer FVIII half‐life ( p = 0.021) and lower clearance ( p = 0.027). Body mass index (BMI) correlated positively with IVR ( p = 0.007) while younger age was associated with higher clearance ( p = 0.037). No significant differences in PK parameters were observed between plasma‐derived and recombinant FVIII concentrates, except for higher AUC with plasma‐derived concentrates.
Conclusion
FVIII PK in Tunisian PWH‐A shows substantial inter‐individual variability. VWF:Ag levels, age and BMI were associated with PK parameters, supporting the implementation of individualized PK‐guided prophylaxis in Tunisia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Haemophilia Treatment Centre, Aziza Othmana Hospital, Tunis, Tunisia.
- Department of Hematology, Aziza Othmana Hospital, Tunis, Tunisia.
- Department of Pharmacology, Fattouma Bourguiba Hospital, Monastir, Tunisia.
Zitieren
APA
Neji, S., Ghali, O., Said, M., Borji, W. E., Chaabane, A., & Gouider, E. (2026). Beyond Body Weight: Biological and Clinical Determinants of Factor VIII Pharmacokinetics in Tunisian Patients. Haemophilia, 32(6), 1413-1420. https://doi.org/10.1111/hae.70335
Vancouver
Neji S, Ghali O, Said M, Borji WE, Chaabane A, Gouider E. Beyond Body Weight: Biological and Clinical Determinants of Factor VIII Pharmacokinetics in Tunisian Patients. Haemophilia. 2026;32(6):1413-1420. doi:10.1111/hae.70335
BibTeX
@article{Neji2026,
author = {Neji, Sameh and Ghali, Ons and Said, Maha and Borji, Wijdene El and Chaabane, Amel and Gouider, Emna},
title = {Beyond Body Weight: Biological and Clinical Determinants of Factor VIII Pharmacokinetics in Tunisian Patients},
journal = {Haemophilia},
year = {2026},
volume = {32},
number = {6},
pages = {1413--1420},
doi = {10.1111/hae.70335}
}
EUVIMED